Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Immunotherapy
>>
Phase 3
«
1
2
3
4
5
6
7
8
9
10
11
12
13
...
14
15
»
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
33
66
99
132
165
198
231
264
297
330
Coviccine (Recombinant
(sf9) Coronavirus Vaccine) / Sichuan University, WestVac Biopharma
Mabtas
(rituximab biosimilar) / Intas
adjuvant CpG 1018
/ Dynavax
budigalimab
(ABBV-181) / AbbVie
galunisertib
(LY2157299) / Eli Lilly
Sputnik-V
(Gam-COVID-Vac Lyo) / Gamaleya Research Institute
botensilimab
(AGEN1181) / Agenus
Qarziba
(dinutuximab beta) / Jazz
linrodostat
(BMS-986205) / BMS, Ono Pharma
monalizumab
(IPH2201) / AstraZeneca, Innate
vidutolimod
(CMP-001) / Regeneron
ImmuFact
(eftilagimod alpha) / Immutep
Mvabea
(MVA-mBN226B) / Bavarian Nordic
sasanlimab
(PF-06801591) / Pfizer
Breyanzi
(lisocabtagene maraleucel) / BMS
Qdenga
(dengue tetravalent vaccine [live, attenuated]) / Takeda
bempegaldesleukin
(NKTR-214) / Nektar Therap, BMS, Ono Pharma
mezigdomide
(CC-92480) / BMS
volrustomig
(MEDI5752) / AstraZeneca
BNT327
/ BioNTech
Diamyd
(rhGAD65/alum) / Diamyd Medical
Pexa-Vec
(pexastimogene devacirepvec) / SillaJen, Transgene
Removab
(catumaxomab) / NeoPharm, Trion Pharma
cetrelimab
(JNJ-63723283) / J&J
domvanalimab
(AB154) / Arcus Biosci, Gilead
favezelimab/pembrolizumab
(MK-4280A) / Merck (MSD)
patritumab deruxtecan
(U3-1402) / Daiichi Sankyo, Merck (MSD)
Cejemly
(sugemalimab) / CStone Pharma
ProstVac
(rilimogene galvacirepvec) / Bavarian Nordic
Qibeian
(iparomlimab/tuvonralimab) / Sound Biologics, Qilu Pharma
SHR-A1921
/ Jiangsu Hengrui Pharma
Zygel
(cannabidiol gel) / Paragon Biosci
rilvegostomig
(AZD2936) / AstraZeneca
sabatolimab
(MBG453) / Novartis
zanidatamab
(ZW25) / Jazz
Abecma
(idecabtagene vicleucel) / BMS, 2seventy bio
Tice BCG
(live attenuated bacillus Calmette-Guerin) / Merck (MSD), Texas A&M University
VAC18193
/ J&J
fianlimab
(REGN3767) / Regeneron
LucaVax
(tertomotide) / GemVax & KAEL
amlitelimab SC
(KY1005 SC) / Sanofi
golcadomide
(CC-99282) / BMS
reparixin
(DF 1681Y) / Dompe
rocatinlimab
(KHK4083) / Amgen
vibostolimab/pembrolizumab
(MK-7684A) / Merck (MSD)
Molgradex
(molgramostim) / Savara, Nobelpharma
IBI-310
(ipilimumab biosimilar) / Innovent Biologics
Nuvion
(visilizumab) / PDL
OvaRex
(oregovomab) / CanariaBio
Stimuvax
(tecemotide) / EMD Serono, Ono Pharma
«
1
2
3
4
5
6
7
8
9
10
11
12
13
...
14
15
»